title: Hemodynamic effects of single-dose vardenafil in subjects receiving maraviroc.
authors.forename: Manoli
authors.initials: M
authors.lastname: Vourvahis
authors.forename: Juanzhi
authors.initials: J
authors.lastname: Fang
authors.forename: Isabelle
authors.initials: I
authors.lastname: Huyghe
authors.forename: Jayvant
authors.initials: J
authors.lastname: Heera
mesh_terms: D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D018592:Cross-Over Studies; D003510:Cyclohexanes / Q000494:pharmacology / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D023581:HIV Fusion Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D000077592:Maraviroc; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D016037:Single-Blind Method; D013450:Sulfones / Q000494:pharmacology / Q000627:therapeutic use; D014227:Triazines / Q000494:pharmacology / Q000627:therapeutic use; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000069058:Vardenafil Dihydrochloride; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D003510:Cyclohexanes; D023581:HIV Fusion Inhibitors; D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D013450:Sulfones; D014227:Triazines; D014230:Triazoles; D014665:Vasodilator Agents; D000069058:Vardenafil Dihydrochloride; D000077592:Maraviroc